Oric Pharmaceuticals Inc. (ORIC) Social Stream
ORIC PHARMACEUTICALS INC (ORIC) Price Targets From Analysts
Use the tables below to see what analysts covering ORIC PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 24 months, ORIC's average price target has gone down $32.67.
ORIC reports an average of 281.77% for its upside potential over the past 47 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ORIC Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 43 weeks, ORIC's average broker recommendation rating worsened by 0.67.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- ORIC has a higher upside potential (average analyst target price relative to current price) than 899.19% of all US stocks.
- ORIC PHARMACEUTICALS INC's number of analysts covering the stock is higher than 790.61% of stocks in the small market cap category.
- In the context of Pharmaceutical Products stocks, ORIC PHARMACEUTICALS INC's variance in analysts' estimates is lower than -451.05% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, ORIC PHARMACEUTICALS INC's average analyst price target is greater than 556.03% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ORIC PHARMACEUTICALS INC are AKUS, PNT, and ANNX.
Is ORIC a Buy, Hold or Sell? See the POWR Ratings now!